Classification of headaches
|
|
- Milton Fields
- 5 years ago
- Views:
Transcription
1 Classification of headaches
2
3 Pain sensitive structures Skin, subcutaneous tissue, periosteum, arteries, muscles, eye, ear, pharynx, sinuses, basal dura, nerves Extracranial structures: well localized pain Intracranial structures: diffuse pain Supratentorial origin: trigeminal distribution fronto-temporal region Infratentorial origin: occipital region
4 Classification of headaches Primary headaches OR Idiopathic headaches Secondary headaches OR Symptomatic headaches THE HEADACHE IS ITSELF THE DISEASE NO ORGANIC LESION IN THE BEACKGROUND TREAT THE HEADACHE! THE HEADACHE IS ON LY A SYMPTOM OF AN OTHER UNDERLYING DISEASE TREAT THE UNDERLYING DISEASE!
5 SECONDARY, SYMPTOMATIC HEADACHES THE HEADACHE IS A SYMPTOM OF AN UNDERLYING DISEASE, e.g. Sinusitis Glaucoma Eye-strain Hypertension Fever Anaemia, hypoxia, hypercapnia, hypoglycaemia Temporal arteriitis Cervical spondylosis Meningitis, encephalitis Brain tumor, meningeal carcinomatosis Haemorrhagic stroke
6 Secondary headache disorders Headache attributed to... head and/or neck trauma cranial or cervical vascular disorder non-vascular intracranial disorder a substance or its withdrawal Infection disorder of homoeostasis disorder of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth or other facial or cranial structures psychiatric disorder cranial neuralgias and central causes of facial pain
7 HISTORY AND EXAMINATIONS SHOULD CLARIFY IF THE PATIENT HAS PRIMARY OR SECONDARY HEADACHE IS THERE ANY URGENCY IN CASE OF PRIMARY HEADACHE ONLY THE HEADACHE ATTACKS SHOULD BE TREATED ( ATTACK THERAPY ), OR PROPHYLACTIC THERAPY IS ALSO NECESSARY ( PREVENTIVE THERAPY, INTERVAL THERAPY )
8 Primary, idiopathic headaches Tension type of headache Migraine Cluster headache Other, rare types of primary headaches
9 Differentiation of the primary headaches History!!! Aura sign Intensity 10 grades scale Localization Characteristics Does he/she work further? Influenced by physical activity? Accompanying signs Reaction to common pain killers
10 TENSION TYPE OF HEADACHE EPISODIC FORM USUALLY AFTER STRESS SITUATION; ANXIETY, DEPRESSION IS FREQUENT NO ACCOMPANYING SIGNS; IN SEVERE ATTACK PHOTO- OR PHONOPHOBIA MAY OCCUR EPISODIC TENSION TYPE OF HEADACHE; LESS THAN 15 DAYS/MONTH; PERIODICITY PROFILE DURATION: 30MIN-7DAYS; IN CHRONIC FORM, COULD BE CONSTANT, CONTINUOUS DULL, BORING PAIN; DIFFUSE OR BAND LIKE; PRESSING, STRAINING, NOT TOO SEVERE PHYSICAL ACTIVITY DOES NOT INCREASE THE INTENSITY CHRONIC TENSION TYPE OF HEADACHE; MORE THAN 15 DAYS/MONTH; PERIODICITY PROFILE JAN FEB MAR APR MAY MON TUE WED THU FRI
11 Treatment of tension type of headache Acute, episodic form: paracetamol, metamizol, NSAID, mg ASA, or noraminophenazon (common pain killers) Indication of prophylactic treatment: tension type of headache in at least 15 days per month
12 Prophylactic treatment of the chronic tension type of headache Tricyclic antidepressants (amitryptiline, clomipramine) Guidelines: Start with low dose (10-25 mg) and increase the dose if there is no beneficial effect after 1-2 weeks Maximal dose should not be more than 75 mg/day Change to other tricyclic antidepressant only after 6-8 weeks Ask the patient to use headache diary Use the tricyclic antidepressant for 6-9 months Decrease the dose gradually
13 Prophylactic treatment of the chronic tension type of headache First choice of drug: amitryptiline (Teperin tabl, 25 mg) 1st week: 25 mg in the evening 2nd week: 50 mg in the evening 3rd week: 75 mg in the evening continuously Change to other drug (e.g. clomipramine) if there is no beneficial effect within 6 weeks
14 Common side effects of tricyclic antidepressants Anticholinergic side effects: Dry mouth Increased pulse rate Urinary retention (in prostate hyperplasia!!!) Increased intraocular pressure (glaucoma!!!) Sleepiness or hyperactivity Serotonine syndrome (do not use if the patient takes SSRI drug)
15 If the patient does not tolerate the TCA drugs, or cannot be administared because of danger of interaction Anxiolytics (e.g.: alprasolam, clonazepam ) + selective antidepressants (e.g. SSRI) Change of lifestyle Psychotherapy, psychological treatments, biofeedback, behavioral therapy, relaxation methods
16 CT?
17 MIGRAINE with aura classic migraine without aura common migraine with prolonged aura complicated migraine Aura H e a d a c h e Common M Classic M Complicated M
18 MIGRAINE AURA SIGNS IN 20% OF ATTACKS; USUALLY VISUAL AURA ZIG-ZAG LINES, BRIGHTING SPOTS ACCOMPANYING SIGNS: PHONOPHOBIA DURATION: 2-72 HOURS SEVERE PAIN; MOSTLY UNILATERAL; PULSATING; PHYSICAL ACTIVITY INCREASES THE INTENSITY PHOTOPHOBIA PERIODICITY PROFILE NAUSEA VOMITUS JAN FEB MAR APR MAY ALCOHOL, ANXIETY, VASODILATORS, COLD WIND, MENSTRUATION MAY PROVOKE
19 Migraine: epidemiology Life-time prevalence 10%-12% 1% chronic migraine (>15 days/months) Sex ratio 2.5 (f) to 1 (m); in childhood 1 to 1 Mean frequency 1.2/month Mean duration 24 h (untreated) 10% always with aura, >30% sometimes with aura 30% treated by physicians
20 Migraine: pathophysiology Genetic disposition, hormonal influence Activation of trigeminovascular system Braistem nuclei trigeminal nucleus vessels of dura neurovascular inflammation caused by neuropeptides (VIP, CRGP ) Neurovascular inflammation and dilation of intracranial vessels Spreading Depression as mechanism of aura
21 Migraine WITHOUT AURA Typical headache 2/4 Unilateral Severe Pulsating Physical activity aggravates Accompanying signs 1/2 Photophobia and phonophobia Nausea, or vomitus WITH AURA + VISUAL SENSORY MOTOR SPEECH DISTURBANCE before migraineous headache AURA SYMPTOMS USUALLY<1/2 HOUR LESS THAN 1 HOUR
22 30 MIGRAINE WITH AURA DURING AURA: VASOCONSTRICTION HYPOPERFUSION DURING HEADACHE VASODILATION HYPERPERFUSION BUT: AURA SYMPTOM IS NOT CONSEQUENCE OF VASOCONSTRICTION INDUCED HYPOPERFUSION CUASE OF THE AURA: SPREADING DEPRESSION. Depolarization wave that moves across the cortex at a rate of 3 5 mm/min, followed by prolonged nerve cell depression THE VASOCONSTRICTION AND HYPOPERFUSION ARE CONSEQUENCES OF THE SPREADING DEPRESSION SPREADING DEPRESSION AURA VASOCONSTRICTION, HYPOPERFUSION
23 IMPORTANT TO KNOW! MIGRAINE WITH AURA IS A RISK FACTOR FOR ISCHAEMIC STROKE THEREFORE PATIENTS SUFFERING FROM MIGRAINE WITH AURA SHOULD NOT SMOKE!!! SHOULD NOT USE ORAL CONTRACEPTIVE DRUGS!!! THE PROPROTION OF PATENT FORAMEN OVALE IN PATIENTS WITH MIGRAINE WITH AURA IS ABOUT 50-55%! (IN THE POPULATION IS ABOUT 25%).
24 Is there a relationship between aura and patent foramen ovale? Paradoxic emboli theory is not likely Shunting of venous blood to the arterial side could be the reason no breakdown of certain amines (5HT) in the lung! Comorbidity could be also an explanation. However, closure of patent foramen ovale decreases the frequency of migraine attacks. BUT! Migraine is a benign disease. Please do not indicate closure of patent foramen ovale just because of migraine with aura!
25 Therapy expectations of the patients No side effect Fast and effective analgetic effect Easy to use No return of headache Permanent effect Successful treatment: pain free after 2 hrs, or pain relief from severe to mild pain, no return of pain within 24 hours, good efficacy in 2 of 3 attacks
26 Treatment of migraine Attack treatment Prophylactic treatment Not specific Aspirin NSAID Antiemetics Paracetamol Noraminophenazon Specific Ergotamin Dihydroergotamin Selective 5-HT 1B/1D agonists (triptans) Beta-receptor blockers Ca-channel antagonists Antiepileptics Antidepressants
27 Treatment of migraine attack Try to sleep Antiemetics Analgetics Ergot derivatives Triptans
28 Treatment of migraine attack I. Antiemetics 1. Metoclopramid (Cerucal tabl 10 mg) mg per os 20 mg rectal 10 mg parenteral 2. Domperidon (Motilium tabl 10 mg) mg per os
29 Treatment of migraine attack II. Analgetics 1. ASA (Aspirin, Colfarit, etc) mg per os 500 mg parenteral (Aspisol i.v.) 2. Paracetamol (Rubophen, Panadol, etc) mg per os 3. NSAIDs Ibuprofen (Ibuprofen, Humaprofen, etc) mg per os Diclofenac (Voltaren, Cataflam etc)50 mg per os Naproxen (Naprosyn, Apranax) mg per os
30 Treatment of migraine attack III. Ergot derivatives 1. Ergotamin tartarate 2-4 mg per os, sublinguali or rectal 1 mg nasal spray 2. Dihydrergotamin (Neomigran) nasal spray no more available
31 Treatment of migraine attack IV. Combinations in Hungary Migpriv: lizin-acetylsalicilate + metoclopramid Quarelin: aminophenazon+coffein+drotaverin Kefalgin ergotamin tartarate+ atropin+coffein+aminophenazon
32 Treatment of migraine attack V. Triptans 1. Sumatriptan (Imigran 6 mg inj, 50 and 100 mg tabl, Imitrex nasal spray, supp, Glaxo) 6 mg sc with autoinjector mg per os, nasal spray 20 mg 2. Zolmitriptan (Zomig, Zeneca) 2,5 5 mg 3. Naratriptan (Naramig, Glaxo) 2,5 mg 4. Rizatriptan (Maxalt, MSD) 5 10 mg per os 5. Eletriptan (Relpax, Pfizer) mg per os 6. Frovatriptan (Smith-Kleine Beecham) 2,5 mg per os 7. Avitriptan (Bristol-Myers Squibb) mg 8. Alniditan (Janssen) 2 4 mg, nasal spray 40
33 Contraindications of triptans Ischemic heart disease, angina pectoris, myocardial infarction Ischemic stroke Not treated hypertension, arrhythmia Long-lasting aura Hemiplegic or basilar migraine
34 The ideal triptan Effective Rapid onset No recurrence Good consistency Different applications Good tolerability No interactions Cheap
35 Attack treatment in emergency Very severe migraine attack / status migrainosus: Triptan (sumatriptan 6 mg s.c.) Lysin-ASA 1,000 mg i.v. Antiemetics i.v. Steroids i.v.
36 Strategy of treatment of migraine attacks Step care accross or within attacks 1: NSAID 2: ergot 3: triptan Stratified care do not go through all the steps, but drug can be chosen depending on the severity of the attack
37 Prophylactic treatment of migraine Indication: 2 or more attacks/month attacks At least one long (>4 days) attack or aura/month Start of prophyalactic treatment: gradually Duration of prophylactic treatment: 2-9 months Stop of prophylactic treatment: gradually, within 4 weeks Use headache diary INFORM THE PATIENT ABOUT THE PROPHYLACTIC TREATMENT!!!
38 Aims of prophylactic treatment of migraine To decrease the frequency of attacks To decrease the intensity of the pain To increase the efficacy of attack therapy
39 Prophylactic treatment of migraine Beta-receptor-blockers (propranolol) Calcium channel blockers (flunarizine) Antiepileptics (valproic acid) Tricyclic antidepressants (amitriptyline) Topiramate (Topamax) Serotonin antagonists NSAID Blood pressure Pulse rate Depression in the history? BMI Epilepsy? Essential tremor? Tension type of headache? Pregnancy?
40 Beta-receptor-blockers (propranolol 2x20-40 mg) Calcium channel blockers (flunarizine, 10 mg every evening) Side effects: provokes depression, increases appetite, cause sleepiness Tricyclic antidepressants (amitryptiline, mg every evening) Antiepileptics (valproic acid, 2x mg) Use: hypertension, tachycardia, essential tremor Do not use: hypotension, bradicardia, heart conduction disturbances, atshma Do not use: obesity, maior depression in the history Use: if tension type of headache is present besides migraine Do not use: see above Few side effects, but pregnancy should be avoided
41 Other prophylactic treatment of migraine Change of life-style Regular, not exhausting physical activities Cognitive behavioral therapy Regular sleeping Avoid the precipitating factors Acupuncture?
42 Migraine and pregnancy Migraine without aura in >70% of women less frequent or absent (prognostic factor: menstrual migraine) Significantly more manifestation of migraine with aura Acute treatment: paracetamol; NSAIDs in second trimenon Triptans not allowed Prophylaxis: magnesium, metoprolol, (fluoxetine)
43 Migraine in childhood I Prevalence 5% Sex ratio 1:1 (boys with good prognosis) Abdominal symptoms often predominant Characteristics of attacks as in adulthood except shorter duration of attacks Short sleep very effective
44 Migraine in childhood II 60 Acute treatment: First choice: ibuprofen 10 mg/kg Second choice: paracetamol 15 mg/kg Third choice: sumatriptan nasal spray mg Prophylaxis: Flunarizine 5-10 mg Propranolol 80 mg Non-drug therapy very effective
45 Complicated migraine Persisting aura signs even after the headache phase Ophthalmoplegic migraine Hemiplegic migraine
46 CLUSTER HEADACHE ACCOMPANYING SIGNS UNILATERAL SWEATING ALCOHOL, COLD WIND, VASODILATORS, ANXIETY, BUT ALSO SLEEP PROVOKE DURATION OF AN ATTACK: MINUTES; DURATION OF A CLUSTER PERIOD: 3-16 WEEKS REDISCH FACE NASAL CONGESTION, OR RUNNING OF NOSE FREQUENTLY AT NIGHT; UNILATERAL - AROUND THE EYE; THE PAIN IRRADIATES TO THE TEMPORAL REGION PERIODICITY PROFILE MON TUE WED THU CONJUNCTIVAL INJECTION; LACRIMATION, TEARING; PUPILLARY DISTURBANCE (ANISOCORIA, HORNER S SYNDROME)
47 CLUSTER HEADACHE Periodicity profile weeks
48 Treatment of cluster attack Oxygen:7 liters/min 100% oxigén for 15 minutes Effective in 75% of patients within 10 minutes Sumatiptan 6 mg s.c., mg per os Ergot derivatives (lot of side effects) Anaesthesia of the ipsilateral fossa sphenopalatina 1 ml 4% Xylocain nasal drop The head is turned back and to the ipsilateral side in 45 degree
49 Prophylactic treatment of the episodic form of cluster headache Prednisolon Treatment: 1-5. days 40 mg days daily 30 mg days daily 20 mg days daily 15 mg days daily 10 mg days daily 5 mg nothing
50 Prophylactic treatment of the chronic form of cluster headache Lithium carbonate Daily mg Can be decreased after 2 weeks remission Control of serum level is necessary (0,4-0,8 mmol/l)
51 Differentiation between primary headaches Aura sign Intensity 10 grades scale Localization Characteristics Does he/she work further? Influenced by physical activity? Accompanying signs Reaction to common pain killers Duration History!!! Migraine Tension type h. Cluster h. Yes 8-9 Unil. Throbbing No Yes Yes No 2-72 hrs No 5-6 Band-like Pressing Yes No No Yes? No 10 Ocular Severe No No Yes! No ¼-3 hrs
52 Cluster headache and trigemino-autonomic cephalgias Trigemino-autonomic cephalgias (TAC) Cluster headache SUNCT-syndrome Paroxysmal hemicrania (Hemicrania continua)
53 71 Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing: SUNCT Rare neuralgiform pain around the eye Male predominance Conjunctival injection and lacrimation Duration: ¼-2 minutes, no refracter period 5-30 attacks / hour for days, weeks Symptom free periods (for months, years) interrupt the disease Treatment:??? lamotrigine Differential diagnosis: cluster headache, trigeminal neuralgia
54 Episodic paroxysmal hemicrania Duration: 2-30 minutes Usually more than 5x/day Indomethacine prevents the headache At least one vegetative sign (lacrimation, conjunctival injection, nasal congestion, running of nose, ptosis, miosis) Epizodic: from 7 days till one year, interrupted by more than 1 month pain free periods Chronic: longer than one year, or the remissions last less than 1 month
55 Hemicrania continua Duration > 3 months Unilateral, always the same side No pain-free period Moderate, sometimes severe in intensity At least one vegetative sign (lacrimation, conjunctival injection, nasal congestion, running of nose, ptosis, miosis) Indomethacin prevents the headache
56 Symptomatic, secondary headaches Secondary headaches OR Symptomatic headaches THE HEADACHE IS ON LY A SYMPTOM OF AN ANOTHER UNDERLYING DISEASE TREAT THE UNDERLYING DISEASE!
57 Symptomatic, secondary Tumor Progressing headache Neurological signs Nausea, vomitus (Epilepsy) Change of behaviour headaches Cerebral hemorrhage Sudden onset Neurological signs Nausea, vomitus (Epilepsy especially in case of sinus thrombosis) Inflammation (meningitis, encephalitis) Acute or subacute onset Fever, meningeal signs Neurological signs in case of encephalitis Progressing headache, confusion Epilepsy Diff. dg CT, MR CSF EEG
58 Headaches - urgency Urgency is necessary if: - previously the patient had no headache - change of characteristics of pain - headache after the fifth decade - headache with sudden onset - progressing headache - headache with neurological signs
59 Diagnostic procedures History! and examination X-ray EEG (meningitis, encephalitis, uraemia ) cerebral CT (tumor, stroke) cranial MR (tumor, vascular malformation, demyelinisation) Examination of CSF (inflammation, SAH) ENT, dentist, internist
60 Trigeminal neuralgia In middle or older ages Males:females ratio: 2:3 Incidence: 4-5/ /year Prevalance: 30/ V/2, V/3 V/1 rare (less than 5%) Right sided > left sided Usually no neurological sign In remission no complaint
61 Trigeminal neuralgia signs and symptoms Symptomatic or idiopathic (?) forms Severe, shooting, sharp pain (like a lightening) danger of suicide Sudden onset and end Short duration (usually ca. 5 sec., but might be repeated several hundreds times/day); always<2 min. Respects the territory of a trigeminal branch The pain paroxysm is followed by 2-3 min. refractory period Trigger points: not nociceptive stimuli, but touch may provoke Previous Dental or ENT treatment
62 Trigeminal neuralgia Idiopathic: 20 years ago: 90%. Symptomatic Pons (MS), cerebello-pontine angle, pyramid Mandibula, teeth, sinuses. Microvascular compression and local demyelinization
63 Trigeminal neuralgia - therapy Baclofen (GABA-B rec agonist), NNT:1,4 Carbamazepine (Na-channel), NNT:1,4-1,7 Lamotrigin (Na channel ), NNT:2,1 Gabapentin, (Ca channel ), NNT: 3,2-3,8 Phenytoin, Valproic acid, Clonazepam, Lidocain, Start wit low dose, increase after 2-3 days till the effective dose, or intolerable side effects, or maximal dose -- tolerance Spontaneous remission is not rare
64 Conservative treatment or surgery Success of medicine therapy Side effect of medicine therapy Risk of surgery 80
65 Glossopharyngeal neuralgia 100x less frequent than the trigeminal neuralgia Localization of pain: pharynx, Eustachian tube, middle ear Provoke: swallowing, yawning, laughing, chewing Cause: microvascular compression, elongated styloid process, tumor of cerebello-pontin angle, tumor of base of skull, nasopharyngeal cc., peritonsillar abscess
66 Postherpetic neuralgias Herpes zoster ophthalmicus Herpes zoster infection of the Gasserian ggl. Eruptions usually in V/1 region Eruptions occur 4-5 days after severe pain of V/1 Long-lasting, burning pain, superimposed by attacks of pain Treatment: acyclovir in acute phase Treatment of neuralgia: carbamazepine, phenytoin, TCA,
67 Facial pains Tolosa-Hunt syndrome (ophthalmoplegia dolorosa) granulomatose inflammation in cavernous sinus, superior orbital fissure Treatment: steroid Gradenigo s syndrome: otitis media inflammation of apex of petrous bone lesion of ipsilateral abducent nerve and facial pain around the ear and forehead
68 Atypical facial pain Frequently after dental treatment No dental cause Signs are not typical for trigeminal neuralgia Continuous, not severe pain Treatment = treatment of chronic tension type of headache
69 Posttraumatic headache Similar to the tension type of headache Preceding head trauma Frequently not immediately after the traume Treatment = treatment of chronic tension type of headache
70 Headache of cervical origin Cervical pain radiating to the occipital region Head movement provokes the pain Lidocain infiltration NSAID: mg indomethacin, mg piroxicam (Hotemin, Feldene), muscle relaxants, etc Other methods (physiotherapy, TENS) Surgical methods (CV-CVII fusion of vertebrae)
71 Arteriitis temporalis Arteriitis temporalis (age>50y, We>50 mm/h) Autoimmune disease, granulomatose inflammation of branches of ECA Unilateral headache Pulsating pain, more severe at night Larger STA 1/3 jaw claudication inflammation of internal maxillary artery Weakness, loss of appetite, low fever, Danger of thrombosis of ophthalmic or ciliary artery!!! Amaurosis fugax may precede the blindness Treatment: steroid mg methylprednisolone decrease the dose after 1-2 weeks to 10 mg!!! Diagnosis: STA biopsy. BUT Start the steroid before results of biopsy!!! We, pain decrease
72 Carotid dissection After neck trauma, extensive neck turning, or spontaneous Neck pain, headache Horner s syndrome Lower ranial nerve lesion Stroke Diagnosis: carotid duplex, MRI-T1
73 Headaches, provoked by medicines Addiction to pain killers ergotamine, coffein, barbiturates, ASA When the effect of the pain killer decreases, the headache increases Stop the drugs, if necessary start indomethacine or carbamazepine Vasodilators Nitrates Dipyridamol
Classification of headaches
Classification of headaches Primary headaches OR Idiopathic headaches Secondary headaches OR Symptomatic headaches THE HEADACHE IS ITSELF THE DISEASE NO ORGANIC LESION IN THE BEACKGROUND TREAT THE HEADACHE!
More informationHeadache. László Oláh
Headache László Oláh www.i-h-s.org Pain sensitive structures Skin, subcutaneous tissue, periosteum, arteries, muscles, eye, ear, pharynx, sinuses, basal dura, nerves Pain sensitive structures Skin, subcutaneous
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationIndex. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.
Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369
More informationDisclosures. Objectives 6/2/2017
Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More informationChronic Daily Headaches
Chronic Daily Headaches ANWARUL HAQ, MD, MRCP(UK), FAHS DIRECTOR BAYLOR HEADACHE CENTER, DALLAS, TEXAS DISCLOSURES: None OBJECTIVES AT THE CONCLUSION OF THIS ACTIVITY, PARTICIPANTS WILL BE ABLE TO: define
More informationMIGRAINE A MYSTERY HEADACHE
MIGRAINE A MYSTERY HEADACHE The migraine is a chronic neurological disease that is characterized by moderate to severe episodes of headache that is mostly associated with other central nervous system (CNS)
More informationHow do we treat migraine? New SIGN Guidelines
How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood
More informationA synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN
A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline Scottish intercollegiate Guidelines Network SIGN November 2008. PETER FRAMPTON MSc MCOptom BAppSc (Optom)(AUS)
More informationMIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.
MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am
More informationAdult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention
Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network
More informationÇiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE
Headache in children and adolescents Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE Dept. of Psychiatry of Childhood and Adolescence Medical University of Vienna, Vienna, Austria Impact
More informationHeadache Assessment In Primary Eye Care
Headache Assessment In Primary Eye Care Spencer Johnson, O.D., F.A.A.O. Northeastern State University Oklahoma College of Optometry johns137@nsuok.edu Course Objectives Review headache classification Understand
More informationHEADACHE: Benign or Severe Dr Gobinda Chandra Roy
HEADACHE: Benign or Severe Dr Gobinda Chandra Roy Associate Professor, Department of Medicine, Shaheed Suhrawardy Medical College and Hospital Outlines 1. Introduction 2. Classification of headache 3.
More informationHeadache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis
Headache Master School Japan-Osaka 2016 II. Management of refractory headaches Case Presentation 2. SUNCT/SUNA: concept, management and prognosis Noboru Imai(Department of Neurology, Japanese Red Cross
More informationCase Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches
Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily
More informationOH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES
1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International
More informationHEADACHES THE RED FLAGS
HEADACHES THE RED FLAGS FAYYAZ AHMED CONSULTANT NEUROLOGIST HON. SENIOR LECTURER HULL YORK MEDICAL SCHOOL SECONDARY VS PRIMARY HEADACHES COMMON SECONDARY HEADACHES UNCOMMON BUT SERIOUS SECONDARY HEADACHES
More informationFaculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Karen L. Bremer, MD Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. HEADACHE UPDATE Karen L. Bremer, MD November 10, 2017 karen.bremer@creighton.edu
More informationManagement of headache
Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener,
More informationHeadache. Section 1. Migraine headache. Clinical presentation
Section 1 Headache Migraine headache 1 Clinical presentation It is important to recognize just how significant a problem migraine headache is. It has been estimated that migraine affects 11% of the United
More informationHeadache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology
Headache and Facial Pain Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology Introduction It is the most common neurologic complain The diagnosis usually
More informationMigraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital
Migraine Management Jane Melling Headache nurse Mater Misericordiae Hospital Migraine facts Among the most common disorders of the nervous system 3 rd most prevalent medical disorder on the planet (lancet
More informationStrategies in Migraine Care
Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More information2) Headache - Dr. Hawar
2) Headache - Dr. Hawar Headache is caused by traction, displacement, inflammation, vascular spasm, or distention of the painsensitive structures in the head or neck. Isolated involvement of the bony skull,
More informationA case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา
ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา 1 CONTENT 1 2 3 Chronic Daily Headache Medical Overused Headache Management Headaches are one of the most common symptoms List
More informationGENERAL APPROACH AND CLASSIFICATION OF HEADACHES
GENERAL APPROACH AND CLASSIFICATION OF HEADACHES CLASSIFICATION Headache is one of the most common medical complaints. Most of the population will have experienced headache, and over 5% will seek medical
More informationTrigeminal Autonomic Cephalalgias. Disclosures. Objectives 6/20/2018. Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018
Trigeminal Autonomic Cephalalgias Rashmi Halker Singh, MD FAHS UCNS Review Course June 2018 Disclosures Honoraria from Allergan and Amgen for advisory board, Current Neurology and Neuroscience Reports
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More informationPrevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.
Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D. Objectives Present patient case Review epidemiology/pathophysiology
More informationSection la. Migraine and other headache syndromes. Migraine. Other headache syndromes G44
Section la Migraine and other headache syndromes Overview of categories dealing with migraine, other headache syndromes, and neuralgia of cranial nerves, in accordance with the ICD-NA, second edition G43
More informationHMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in
HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time
More informationHow could I be having migraine when I don't have a headache?
Migraine Your doctor thinks you may have migraine. Classic migraine attacks start with visual symptoms (often zig-zag colored lights or flashes of light expanding to one side over 10-30 minutes) followed
More informationClassification and WHO ICD-10NA Codes
Classification and WHO ICD-10NA Codes IHS WHO Diagnosis ICHD-II ICD-10NA [and aetiological ICD-10 code for secondary headache disorders] code code 1. [G43] Migraine 1.1 [G43.0] Migraine without aura 1.2
More informationNeuralgias tend to be sudden, brief, intermittent severe, stabbing or lightning pains or electric shock sensations.
Neuralgia is the term used to describe pain arising from a nerve. There are many different neuralgias which have been described in the medical literature, but I will only touch upon a few more common ones.
More informationHeadache Syndrome. Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL
Headache Syndrome Karen Alvarez, D.O Nemours Children s Specialty Care Jacksonville, FL What is a headache? A headache or cephalgia is defined as pain anywhere in the region of head or neck Where does
More informationI have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.
I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. In 1962, Bille published landmark epidemiologic survey of headache among 9,000 school
More informationTrigeminal Neuralgia Association UK. Facing pain together TRIGEMINAL NEURALGIA AN OVERVIEW
Trigeminal Neuralgia Association UK Facing pain together TRIGEMINAL NEURALGIA AN OVERVIEW The TNA UK was established to provide support and information to people affected by trigeminal neuralgia and we
More informationThe trigeminal autonomic cephalalgias (TACs) are a group of. Cluster Headache and Other Trigeminal Autonomic Cephalalgias By Mark Burish, MD, PhD
Downloaded from https://journals.lww.com/continuum by SruuCyaLiGD/095xRqJ2PzgDYuM98ZB494KP9rwScvIkQrYai2aioRZDTyulujJ/fqPksscQKqke3QAnIva1ZqwEKekuwNqyUWcnSLnClNQLfnPrUdnEcDXOJLeG3sr/HuiNevTSNcdMFp1i4FoTX9EXYGXm/fCfrbTavvQSUHUH4eazE11ptLzgCyEpzDoF
More informationONZETRA XSAIL (sumatriptan) nasal powder
ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationCan I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017
Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017 SAH v benign thunderclap headaches Other pathologies not apparent on CT Severe primary headaches: management
More informationHeadache Mary D. Hughes, MD Neuroscience Associates
Headache Mary D. Hughes, MD Neuroscience Associates Case 1 22 year old female presents with recurrent headaches. She has had headaches for the past 3 years. They start on the right side of her head and
More informationHeadache Pain Generators
Objectives 1. Define the major categories of headache. 2. Take a history directed at characterizing a headache pattern in an individual patient and identify the cause or triggers of the headache. 3. Understand
More informationWHY IS MIGRAINE IMPORTANT
WHY IS MIGRAINE IMPORTANT Migraine is a complex disorder characterized by recurrent episodes of headache, most often unilateral and in some cases associated with visual or sensory symptoms collectively
More informationMigraine, Tension, and Cluster Headache: Primary Care for Primary Headaches. Jonathon M. Firnhaber, MD, FAAFP
Migraine, Tension, and Cluster Headache: Primary Care for Primary Headaches Jonathon M. Firnhaber, MD, FAAFP Learning objectives 1. Utilize evidence-based strategies to diagnose patients presenting with
More informationHeadaches in Children and Adolescents. Paul Shillito
Headaches in Children and Adolescents Paul Shillito Topics For Discussion What s different about childhood migraine Chronic daily headache (CDH) Tumours and other things to worry about Management of childhood
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 05.70.10 Subject: Sumatriptan Page: 1 of 6 Last Review Date: March 16, 2018 Sumatriptan Description Sumatriptan
More informationSumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan Page: 1 of 6 Last Review Date: November 30, 2018 Sumatriptan Description Sumatriptan
More informationIshaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert
Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Childhood headache: Is it really difficult to manage? It shouldn t be... But it can be...
More informationNeurological Dilemmas in Primary Care
Neurological Dilemmas in Primary Care David Clark, DO dclark@oregonneurology.com When to test? How to test? Pitfalls in testing? When to treat? How to treat? How long to treat? Neurological Dilemmas Seizure
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: occipital_nerve_stimulation 8/2010 5/2017 5/2018 5/2017 Description of Procedure or Service Occipital nerve
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT
More informationHeadache. Luke Bennetto Consultant Neurologist Engineers House 13 th September 2016
Headache Luke Bennetto Consultant Neurologist Engineers House 13 th September 2016 Contents General thoughts Primary headache Secondary headache I want to curl up in a cave and die I want to drill a
More informationMedication For Migraine Chart: Table 1: Acute Treatment when the attack begins
Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins Page a Analgesics (painkillers) Non-steroidal antiinflammatory drugs (NSAIDs) Prescription required Brand Name Formulation
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT
More informationHeadache Questionnaire
Date: All Headache Patients We would appreciate your cooperation in filling out this form. In our evaluation of headache, your history is typically our most valuable tool for diagnosis and subsequent treatment.
More informationPrimary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0
Primary Care Adult Headache Management Pathway (formerly rth West Headache Management Guideline for Adults) Version 1.0 1 VERSION CONTROL Version Date Amendments made Version 1.0 October 2018 Reformatted
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Alveolar osteitis (dry socket), periodontal pain due to, 436 Aphthous stomatitis, recurrent, mucosal pain due to, 439 440 Arthrocentesis/arthroscopy,
More informationCluster headache (CH): epidemiology, classification and clinical picture
Cluster headache (CH): epidemiology, classification and clinical picture Toomas Toomsoo, M.D. Head of the Center of Neurology East Tallinn Central Hospital 1 INTRODUCTION Cluster headache - known as trigeminal
More informationDubai Standards of Care (Migraine)
Dubai Standards of Care 2018 (Migraine) Preface Migraine is one of the most common problem dealt with in daily practice. In Dubai, the management of migraine is done through various different strategies.
More informationHow to remove the headache of dealing with headaches. Dr. Stefan Schumacher Consultant Neurologist Salford Royal Hospital
How to remove the headache of dealing with headaches Dr. Stefan Schumacher Consultant Neurologist Salford Royal Hospital Case 30 y old woman Sudden headache Vomiting, dizziness, photophobia Recurrent migraines
More information11. HEADACHE 1. Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH
11. HEADACHE 1 Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH We identified articles on the evaluation and management of headache by conducting a MEDLINE search of English language
More informationMigraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital
Migraine Management Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital Referral Criteria for Migraine Migraine Management Migraine Diagnosis Spot on Health Migraine pathway
More informationHeadache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)
Headache Eric Kraus, MD Headache Case This 23 year-old female has headaches behind the right eye that cause her to lay down in a quiet room. They have a throbbing quality and she may vomit. Migraine Headache
More informationSUMAVEL DOSEPRO (sumatriptan succinate) solution for injection
SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit
More informationHEADACHE. Dr Nick Pendleton. September Headache
HEADACHE Dr Nick Pendleton September 2017 Headache Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache Raised ICP
More informationHeadache. Susan Hickenbottom MD, MS February 24, 2015
Headache Susan Hickenbottom MD, MS February 24, 2015 Epidemiology One of most common complaints in primary care 90% of US population 50% at least one severe 25% recurrent disabling attacks 5% chronic daily
More informationMigraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification
28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification
More informationManaging Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital
Managing Headache in Acute Medicine Ben Lovell Consultant Physician in Acute Medicine University College London Hospital Some ED headache stats Arrive by ambulance 31% Median age 39 Worst ever headache
More informationSIGN on the pharmacological management of migraine
GUIDELINES SIGN on the pharmacological management of migraine STEVE CHAPLIN In February 2018, the Scottish Intercollegiate Guidelines Network (SIGN) published a new guideline on the pharmacological management
More informationChapter 2 Diagnosis of Trigeminal Autonomic Cephalalgias
Chapter 2 Diagnosis of Trigeminal Autonomic Cephalalgias Mark J. Stillman Introduction The trigeminal autonomic cephalalgias (TACs) refer to a specific group of primary headaches characterized by unilaterality,
More informationBy Nathan Hall Associate Editor
By Nathan Hall Associate Editor 34 Practical Neurology March 2005 These new rules may change the definition of head pain, but some practitioners may find the new guidelines themselves to be a source of
More informationManagement options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM
Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off
More informationDisclosures. Triptans for Kids 5/16/13
5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS
More informationUpdate on Diagnosis and Management of Migraines
Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More information25/09/2018 HEADACHE. Dr Nick Pendleton
HEADACHE Dr Nick Pendleton September 2018 1 Small Group Work Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache
More informationJuly 2012 Target Population. Adult patients 18 years or older in primary care settings.
Guideline for Primary Care Management of Headache in Adults July 2012 Target Population Adult patients 18 years or older in primary care settings. Exclusions: This guideline does not provide recommendations
More informationManaging Headache in General Practice 2nd Edition
1 Managing Headache in General Practice 2nd Edition Dr Raeburn Forbes Consultant Neurologist November 2012 Email: elaine.johnston@southerntrust.hscni.net Department of Neurology Craigavon Area Hospital
More informationHeadache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, 2016 II. Management of Refractory Headaches Case presentation 1: A case of intractable daily-persistent headache Keio University School
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationCOMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS
ACUTE THEAPIES TIPTANS TICYCLIC ANTIDEPESSANTS When starting acute treatment, healthcare professionals should warn patients about the risk of developing medication-overuse headache. ASPIIN Aspirin (900
More informationHEADACHE P of o. G. G Z u Z l u iani
HEADACHE Prof. G. Zuliani General Statistics Everyone has headaches (HA) Second most common complain after back pain in the population More than 80 million Emergency Room visits in USA per year Frequency
More informationUCNS Course A Review of ICHD-3b
UCNS Course A Review of ICHD-3b Andrew D. Hershey, M.D., Ph.D., FAHS Endowed Chair and Director of Neurology Director, Cincinnati Children s Headache Center Professor of Neurology and Pediatrics University
More informationEfficacy of Acupuncture Treatment for Trigeminal Neuralgia
Efficacy of Acupuncture Treatment for Trigeminal Neuralgia DAOM (Doctor of Acupuncture and Oriental medicine) Candidate: David Kim Abstract: A 47-year-old Caucasian female has been suffering from TMJ on
More informationHeadaches in the Pediatric Emergency Dept
Headaches in Children February 23, 2011 Jinny Tavee, MD Associate Professor Neuromuscular Center Cleveland Clinic Foundation Cleveland, OH 1 Headaches in the Pediatric Emergency Dept Burton Gutierrez Kan
More informationOveruse of barbiturate and opioid containing medications for primary headache disorders Description
Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed
More informationMigranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: June 22, 2017 Migranal Nasal Spray
More information6/4/2018. Headache. Headaches. Headache. Migraine Headaches. Headache. Red Flag signs and symptoms. Imaging CT without contrast.
Presented by M.D. Shepherd, M.D. OH MY ACHING HEAD! Estimated that one half of the adult population is affected by a headache disorder International Society Classification Primary : Tension s 40% of the
More informationTeeth and supporting tissues, e.g. dental. Maxillary sinus, salivary gland
MJDF Facial Pain. Patricia Thomson Always start with SOCRATES S site O onset C character R radiation A associated features T timing E exacerbating/relieving factors S severity Examine the cranial nerves
More informationTreatments for migraine
Treatments for migraine Information for patients and carers Department of Neurology Aberdeen Royal Infirmary Contents Page About this leaflet Abortive medication for migraine Painkillers Antisickness medication
More informationFINANCIAL DISCLOSURE. No relevant financial relationships
Sleep and Headache Paul Mathew, MD, FAHS Director of Continuing Medical Education John R. Graham Headache Center Brigham & Women s Hospital Director of Headache Medicine Cambridge Health Alliance Harvard
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abscess(es) epidural anesthesia-related, 825 826 ACE inhibitors. See Angiotensin-converting enzyme (ACE) inhibitors Acetaminophen for
More informationPRIORITIES AND CLINICAL EFFECTIVENESS FORUM MANAGEMENT OF ADULT HEADACHE
PRIORITIES AND CLINICAL EFFECTIVENESS FORUM MANAGEMENT OF ADULT HEADACHE o This is a new guideline produced jointly by GPs and Consultant Neurologists. o The aim is to reduce referrals to Consultants for
More informationCurrent Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN
Current Migraine Treatment Therapy Daniel Kassicieh, DO, FAAN Migraine a Disease Process Migraines are a chronic disease process similar to many other chronic medical conditions Migraine has a low mortality
More informationClinical Learning Days November 10, 2017
Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion
More information